Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, VET, AVO

New Collaboration Gives Veterans Better Access To Innovative Research Trials

NEW YORK, May 7, 2020 /PRNewswire/ -- Cohen Veterans Bioscience (CVB) announced today it is extending its commitment to the brain health of Veterans by supporting the National Association of Veterans Research Education Foundation (NAVREF) and the new VA Office of Research and Development (ORD) led Partnered Research Program (PRP). As an outcome of the Access to Clinical Trials (ACT) for Veterans initiative, the PRP increases veterans' access to high-quality clinical trials and streamlines the start-up of new, innovative trials to give Veterans access to world-class health solutions. By improving infrastructure, the PRP is helping agencies and organizations to partner more rapidly on critical research trials, specifically targeting the enhanced inclusion of Veterans.

"With critical support from our Champion Circle sponsor, Cohen Veterans Bioscience, and other partners, we have helped establish a program with VA ORD where dedicated facilitators will interface with industry sponsors and coordinate with VA-affiliated non-profit research corporations (NPCs) and VA medical center research services," says Rick Starrs, CEO, NAVREF. "Moving forward, this will expedite study start-up and the evaluation of a new generation of therapeutics for our Veterans and other patients."

One example of the effectiveness of the launch of the PRP is that it allowed the National Institute of Allergy and Infectious Diseases (NIAID) to partner with the VA on its COVID-19 trial, which was rapidly activated in under a week.

"Veterans have made many sacrifices for our country and deserve access to best-in-class healthcare. In a short time, the new Partnered Research Program has already demonstrated that it can enhance the VA's research capacity and position the VA as a leading clinical studies partner," says Magali Haas, MD, PhD, CEO of CVB. "A testament to this accelerated implementation is the VA's new partnership with NIAID on a critically important COVID-19 trial."

As architects of the PRP, NAVREF and ORD will help streamline start-up activities and provide other efficiencies for VA multi-site clinical trials. In doing so, they hope to encourage more industry sponsors and enable Veterans to participate in clinical trials to give them access to new therapeutic interventions.

About Cohen Veterans Bioscience

CVB is a non-profit research biotech dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer from the devastating effects of trauma-related and other brain disorders.



Formed in 1992, the National Association of Veterans' Research and Education Foundations (NAVREF) is the 501(c)(3) nonprofit membership organization of research and education foundations affiliated with Department of Veterans Affairs (VA) medical centers. These nonprofits were authorized by Congress under 38 USC §§7361-7366 to provide flexible funding mechanisms for the conduct of research and education at VA facilities nationwide.

SOURCE Cohen Veterans Bioscience

These press releases may also interest you

at 13:35
Today, AmerisourceBergen kicked off its first-ever ThinkLive Trade virtual event, a three-day online summit geared toward brand, specialty and generic manufacturers. The COVID-19 pandemic has tested the resilience of the healthcare industry and...

at 13:35
Technavio has been monitoring the digital retail marketing market and it is poised to grow by USD 439.57 billion during 2020-2024, progressing at a CAGR of almost 23% during the forecast period. The report offers an up-to-date analysis regarding the...

at 13:35
Data Projections Inc., a Texas audio-visual solutions company, is in part responsible for the successful completion of a lengthy bench trial that was conducted entirely outside the courtroom and solely through the use of conferencing technology. The...

at 13:32
Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") is pleased to report Sandfire Resources Ltd ("Sandfire") has announced by press release on October 27, 2020 that they have entered into a farm-in agreement ("Farm-in") with CBH...

at 13:30
Klick Health today proudly announced that its Co-Founder and Chairman Leerom Segal has been recognized on MM+M and PRWeek's Health Influencer 50 list, alongside some of the most prolific and awe-inspiring physicians, scientists, and healthcare...

at 13:30
The "Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography" report has been added to ResearchAndMarkets.com's offering....

News published on 7 may 2020 at 08:30 and distributed by: